Repurposing 0.5% povidone iodine solution in otorhinolaryngology practice in Covid 19 pandemic
- 1 September 2020
- journal article
- research article
- Published by Elsevier BV in American Journal of Otolaryngology
- Vol. 41 (5), 102618
- https://doi.org/10.1016/j.amjoto.2020.102618
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Optimizing the antisepsis protocol: Effectiveness of 3 povidone–iodine 1.0% applications versus a single application of povidone–iodine 5.0%Journal of Cataract & Refractive Surgery, 2017
- Relationship between Virucidal Efficacy and Free Iodine Concentration of Povidone-Iodine in Buffer SolutionBiocontrol Science, 2016
- Rapid and Effective Virucidal Activity of Povidone-Iodine Products Against Middle East Respiratory Syndrome Coronavirus (MERS-CoV) and Modified Vaccinia Virus Ankara (MVA)Infectious Diseases and Therapy, 2015
- Inactivation of SARS Coronavirus by Means of Povidone-Iodine, Physical Conditions and Chemical ReagentsDermatology, 2006
- Allergic contact dermatitis from povidone‐iodine: a re‐evaluation studyContact Dermatitis, 2005
- A Trial of Povidone-iodine (PVP-I) Nasal Inhalation and Gargling to Remove Potentially Pathogenic Bacteria Colonized in the PharynxKansenshogaku Zasshi, 1999
- Review presentation on povidone-iodine antisepsis in the oral cavity.1993
- Effect of Mouth Rinsing With Two Polyvinylpyrrolidone-Iodine Mixtures on Iodine Absorption and Thyroid Function*Journal of Clinical Endocrinology & Metabolism, 1988
- [Relevance of an iodine allergy to commercial polyvidone-iodine preparations].1983